< Terug naar vorige pagina

Octrooi

Single domain antibodies against sod1 and their use in medicine

The present application relates to the field of single-domain antibodies (also called nanobodies), more particularly single-domain antibodies against SOD1 protein isoforms. It also relates to the use of these nanobodies in medicine. Accordingly, methods to treat a disease using these nanobodies are provided herein. The single-domain antibodies are particularly envisaged for treatment of ALS.
Octrooi-publicatienummer: US9862777
Jaar aanvraag: 2018
Jaar toekenning: 2018
Jaar van publicatie: 2018
Status: Toegewezen
Technologiedomeinen: Farmaceutische producten
Gevalideerd voor IOF-sleutel: Ja
Toegewezen aan: Associatie KULeuven